Pencil Biosciences
Safer gene editing, no breaks
Macclesfield, Cheshire, UK
Pencil Biosciences is a biotechnology company.
How We Help
Problem Statement
To overcome the limitations of current gene-editing technologies, which often rely on creating DNA double-strand breaks or nicks to introduce new genetic material.
Core Technology
A fully synthetic, RNA-guided, non-CRISPR gene-editing system called ApGet, which is modular and smaller than Cas-based technologies.
Key Differentiators
Gene-editing platform introduces new genetic material without causing DNA double-strand breaks or nicks.; Non-CRISPR based system.; Significantly smaller than Cas-based technologies.; Modular and fully synthetic platform.; Highly efficient "knock-in" of donor DNA sequences.
Company Info
- Business Model
- Hybrid
- Total Funding
- 10,400,000
- Website
- www.pencilbiosciences.com
Categories
Technologies
Clinical & IP
Clinical Validation
Platform-stage technology focused on oncology and genetic diseases. Founded 2018, raised £5.6M seed funding plus Innovate UK grant. Early-stage platform development; no clinical trials initiated yet.
MedStartr Index Score
?What do you think of Pencil Biosciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.